1767MO External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa) starting androgen deprivation therapy (ADT) in the docetaxel (Doc) or abiraterone (AAP) phase III STAMPEDE trials

Chris Parker ,D Van Der Wal,L.R Murphy,A Esteva,A Sachdeva,S Lall,V Liu,M.K Parmar,Matthew R Sydes ,Noel W Clarke ,Phuoc T Tran ,Louise Brown ,Eric Chen ,Daniel E Spratt ,Emily Grist ,Nicholas D James ,Lígia Mendes ,John R Griffin ,Felix Y Feng ,Gerhardt Attard

doi:10.1016/j.annonc.2023.09.2717

1767MO External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa) starting androgen deprivation therapy (ADT) in the docetaxel (Doc) or abiraterone (AAP) phase III STAMPEDE trials

Chris Parker , D Van Der Wal + Show 18 more

Open Access

https://doi.org/10.1016/j.annonc.2023.09.2717

Copy DOI

Journal: Annals of Oncology	Publication Date: Oct 1, 2023
Citations: 1	License type: publisher-specific-oa

Affiliation: University College London, CRUK Lung Cancer Centre of Excellence, MRC Clinical Trials Unit, Case Western Reserve University, University Hospitals of Cleveland, Institute of Cancer Research, Royal Marsden Hospital, University of California San Francisco Medical Center

#Starting Androgen Deprivation Therapy #Androgen Deprivation Therapy + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

1767MO External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa) starting androgen deprivation therapy (ADT) in the docetaxel (Doc) or abiraterone (AAP) phase III STAMPEDE trials

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.